相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Autophagy Triggers Tamoxifen Resistance in Human Breast Cancer Cells by Preventing Drug-Induced Lysosomal Damage
Chiara Actis et al.
CANCERS (2021)
Pharmacological approaches to tackle NCLs
Valerjans Kauss et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
The contribution of multicellular model organisms to neuronal ceroid lipofuscinosis research
Robert J. Huber et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
A substrate-specific mTORC1 pathway underlies Birt-Hogg-Dube syndrome
Gennaro Napolitano et al.
NATURE (2020)
Lysosomal proteome analysis reveals that CLN3-defective cells have multiple enzyme deficiencies associated with changes in intracellular trafficking
Carolin Schmidtke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis
Sara E. Mole et al.
LANCET NEUROLOGY (2019)
Tamoxifen blocks retrograde trafficking of Shiga toxin 1 and 2 and protects against lethal toxicosis
Andrey S. Selyunin et al.
LIFE SCIENCE ALLIANCE (2019)
Tamoxifen a pioneering drug: An update on the therapeutic potential of tamoxifen derivatives
Shagufta et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Loss of CLN7 results in depletion of soluble lysosomal proteins and impaired mTOR reactivation
Tatyana Danyukova et al.
HUMAN MOLECULAR GENETICS (2018)
Glucosylceramide synthase inhibition with lucerastat lowers globotriaosylceramide and lysosome staining in cultured fibroblasts from Fabry patients with different mutation types
R. W. D. Welford et al.
HUMAN MOLECULAR GENETICS (2018)
Altered Expression of Ganglioside Metabolizing Enzymes Results in GM3 Ganglioside Accumulation in Cerebellar Cells of a Mouse Model of Juvenile Neuronal Ceroid Lipofuscinosis
Aleksandra Somogyi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
NF-κB Activity Initiates Human ESC-Derived Neural Progenitor Cell Differentiation by Inducing a Metabolic Maturation Program
Lorna M. FitzPatrick et al.
STEM CELL REPORTS (2018)
Secretion and function of Cln5 during the early stages of Dictyostelium development
Robert J. Huber et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2018)
Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity
Benny Zhitomirsky et al.
CELL DEATH & DISEASE (2018)
Tamoxifen prolongs survival and alleviates symptoms in mice with fatal X-linked myotubular myopathy
Elinam Gayi et al.
NATURE COMMUNICATIONS (2018)
Lysosomotropic Drugs: Pharmacological Tools to Study Lysosomal Function
Sandra Pisonero-Vaquero et al.
CURRENT DRUG METABOLISM (2017)
Lysosomal adaptation: How cells respond to lysosomotropic compounds
Shuyan Lu et al.
PLOS ONE (2017)
Lysosomal dysfunction and impaired autophagy in a novel mouse model deficient for the lysosomal membrane protein Cln7
Laura Brandenstein et al.
HUMAN MOLECULAR GENETICS (2016)
Neuroprotective and immunomodulatory effects of raloxifene in the myenteric plexus of a mouse model of Parkinson's disease
Andree-Anne Poirier et al.
NEUROBIOLOGY OF AGING (2016)
Complex I assembly into supercomplexes determines differential mitochondrial ROS production in neurons and astrocytes
Irene Lopez-Fabuel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Tamoxifen regulation of sphingolipid metabolism-Therapeutic implications
Samy A. F. Morad et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2015)
Genetics of the neuronal ceroid lipofuscinoses (Batten disease)
Sara E. Mole et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
The relevance of the storage of subunit c of ATP synthase in different forms and models of Batten disease (NCLs)
David N. Palmer
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Development of new treatments for Batten disease
Sara E. Mole
LANCET NEUROLOGY (2014)
Gene disruption of Mfsd8 in mice provides the first animal model for CLN7 disease
Markus Damme et al.
NEUROBIOLOGY OF DISEASE (2014)
The neuronal ceroid-lipofuscinoses: A historical introduction
Matti Haltia et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease
Carmine Spampanato et al.
EMBO MOLECULAR MEDICINE (2013)
Lysosomal storage diseases-the horizon expands
Rose-Mary Naaman Boustany
NATURE REVIEWS NEUROLOGY (2013)
Age-Related Behavioral Phenotype of an Astrocytic Monoamine Oxidase-B Transgenic Mouse Model of Parkinson's Disease
Christopher A. Lieu et al.
PLOS ONE (2013)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
Globotriaosylsphingosine Accumulation and Not Alpha-Galactosidase-A Deficiency Causes Endothelial Dysfunction in Fabry Disease
Mehdi Namdar et al.
PLOS ONE (2012)
Large-Scale Phenotyping of an Accurate Genetic Mouse Model of JNCL Identifies Novel Early Pathology Outside the Central Nervous System
John F. Staropoli et al.
PLOS ONE (2012)
Transcriptional Activation of Lysosomal Exocytosis Promotes Cellular Clearance
Diego L. Medina et al.
DEVELOPMENTAL CELL (2011)
Tamoxifen as an effective neuroprotectant in an endovascular canine model of stroke
Alan S. Boulos et al.
JOURNAL OF NEUROSURGERY (2011)
Altered sensitivity of cerebellar granule cells to glutamate receptor overactivation in the Cln3Δex7/8-knock-in mouse model of juvenile neuronal ceroid lipofuscinosis
Rozzy Finn et al.
NEUROCHEMISTRY INTERNATIONAL (2011)
Membrane lipidome of an epithelial cell line
Julio L. Sampaio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A Gene Network Regulating Lysosomal Biogenesis and Function
Marco Sardiello et al.
SCIENCE (2009)
Glycosphingolipid Requirements for Endosome-to-Golgi Transport of Shiga Toxin
Hilde Raa et al.
TRAFFIC (2009)
The comparative biology of neuromelanin and lipofuscin in the human brain
K. L. Double et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells
Anu Kallio et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
CLN3p impacts galactosylceramide transport, raft morphology, and lipid content
Elena Rusyn et al.
PEDIATRIC RESEARCH (2008)
Selectively increased sensitivity of cerebellar granule cells to AMPA receptor-mediated excitotoxicity in a mouse model of Batten disease
Attila D. Kovacs et al.
NEUROBIOLOGY OF DISEASE (2006)
The use of tamoxifen to improve height potential in short pubertal boys
NC Kreher et al.
PEDIATRICS (2005)
Ospemifene inhibits the growth of dimethylbenzanthracene-induced mammary tumors in Sencar mice
GT Wurz et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses
SE Mole et al.
NEUROGENETICS (2005)
Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia
SE Lawrence et al.
JOURNAL OF PEDIATRICS (2004)
Neuroprotective activity of tamoxifen in permanent focal ischemia
HK Kimelberg et al.
JOURNAL OF NEUROSURGERY (2003)
Cln3Δex7/8 knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth
SL Cotman et al.
HUMAN MOLECULAR GENETICS (2002)
What is lipofuscin? Defining characteristics and differentiation from other autofluoreseent lysosomal storage bodies
ML Katz et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2002)
In vitro and in vivo biologic effects of Ospemifene (FC-1271a) in breast cancer
TL Taras et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2001)
Reduction of globotriaosylceramide in Fabry disease mice by substrate deprivation
A Abe et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Tamoxifen and carboplatin for children with low-grade gliomas: A pilot study at St. Jude Children's Research Hospital
AW Walter et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2000)
分享论文
